Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59
Published September 25, 2019 · Recall initiated: September 9, 2019
Summary
FDA records drug Class II recall D-1863-2019, published September 25, 2019 and initiated September 9, 2019. Recalling firm: West-Ward Columbus Inc; Status: Terminated; Reported quantity: 32,347 bottles; Lot: Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specificattion
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- West-Ward Columbus Inc
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: HikmaJanuary 15, 2025
- FDAMethotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-WardNovember 1, 2023
- FDALeucovorin Calcium Tablets USP, 10 mg, Rx only, 24 Tablets per bottle, Distr. by: West-Ward PharmaceuticalsAugust 19, 2020
- FDADoxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-countJune 3, 2020
- FDAAnagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc.,September 25, 2019
- FDAAllergy Relief (fexofenadine hydrochrloride) tablets, 180 mg, 5-count carton, Good Neighbor Pharmacy,September 25, 2019
Questions about this recall
Was Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59 recalled?
Yes. FDA published recall D-1863-2019 on September 25, 2019. Reported hazard: Failed Impurities/Degradation Specificattion
What should I do if I have this product?
Voluntary: Firm initiated · Letter